Placebo matching BI 1839100
Sponsors
Boehringer Ingelheim
Conditions
Healthy
Phase 1
A Study in Healthy Men to Test How Well Multiple Doses of BI 1839100 Are Tolerated and How BI 1839100 Influences the Amount of Other Medicines in the Blood
CompletedNCT05738291
Start: 2023-05-01End: 2024-06-14Updated: 2024-11-13
A Study in Healthy Men to Test How Well Different Doses of BI 1839100 Are Tolerated (1490-0003)
CompletedNCT05934955
Start: 2023-07-13End: 2023-10-02Updated: 2023-11-08